Selenium a bust in lung cancerSupplement fails to prevent secondary tumour development Sponge-derived drug extends breast CA survivalEribulin among ‘handful’ of effective agents for metastatic disease Targeted lung cancer drug wows meeting Promising early trial results for crizotinib highlighted in plenary session Tool aids ovarian CA screening Radiation-hormone therapy combo best for high-risk prostate cancer Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Radiation-hormone therapy combo best for high-risk prostate cancer Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say First Previous 66 67 68 69 70 Next Last
